Accuray Incorporated (ARAY)
NASDAQ: ARAY · IEX Real-Time Price · USD
1.620
+0.080 (5.19%)
At close: May 3, 2024, 4:00 PM
1.640
+0.020 (1.23%)
After-hours: May 3, 2024, 7:31 PM EDT
Accuray Revenue
Accuray had revenue of $447.48M in the twelve months ending December 31, 2023, with 7.20% growth year-over-year. Revenue in the quarter ending December 31, 2023 was $107.24M, a -6.55% decrease year-over-year. In the fiscal year ending June 30, 2023, Accuray had annual revenue of $447.61M with 4.12% growth.
Revenue (ttm)
$447.48M
Revenue Growth
+7.20%
P/S Ratio
0.36
Revenue / Employee
$436,994
Employees
1,024
Market Cap
160.65M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2023 | 447.61M | 17.70M | 4.12% |
Jun 30, 2022 | 429.91M | 33.62M | 8.48% |
Jun 30, 2021 | 396.29M | 13.36M | 3.49% |
Jun 30, 2020 | 382.93M | -35.86M | -8.56% |
Jun 30, 2019 | 418.79M | 13.89M | 3.43% |
Jun 30, 2018 | 404.90M | 21.48M | 5.60% |
Jun 30, 2017 | 383.41M | -15.39M | -3.86% |
Jun 30, 2016 | 398.80M | 19.00M | 5.00% |
Jun 30, 2015 | 379.80M | 10.38M | 2.81% |
Jun 30, 2014 | 369.42M | 53.45M | 16.91% |
Jun 30, 2013 | 315.97M | -93.25M | -22.79% |
Jun 30, 2012 | 409.22M | 186.94M | 84.10% |
Jun 30, 2011 | 222.28M | 659.00K | 0.30% |
Jun 30, 2010 | 221.63M | -11.97M | -5.13% |
Jun 30, 2009 | 233.60M | 23.22M | 11.04% |
Jun 30, 2008 | 210.38M | 66.24M | 45.95% |
Jun 30, 2007 | 144.15M | 91.25M | 172.50% |
Jun 30, 2006 | 52.90M | 23.27M | 78.53% |
Jun 30, 2005 | 29.63M | 10.06M | 51.41% |
Jun 30, 2004 | 19.57M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Auna S.A. | 1.03B |
Codexis | 70.14M |
AVITA Medical | 51.57M |
uniQure | 15.84M |
Lineage Cell Therapeutics | 8.95M |
Ovid Therapeutics | 391.70K |
ARAY News
- 2 days ago - Accuray Reports Fiscal 2024 Third Quarter Financial Results - PRNewsWire
- 8 days ago - Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024 - PRNewsWire
- 15 days ago - Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland - PRNewsWire
- 16 days ago - Accuray to Report Third Quarter Fiscal 2024 Financial Results on May 1, 2024 - PRNewsWire
- 5 weeks ago - New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® System - PRNewsWire
- 2 months ago - Accuray Incorporated to Speak at 36th Annual Roth Conference - PRNewsWire
- 2 months ago - Accuray Incorporated to Speak at Oppenheimer 34th Annual Healthcare MedTech & Services Conference - PRNewsWire
- 2 months ago - Quebec Cancer Center is First in Canada to Treat Cancer Patients Using the Accuray Radixact® System - PRNewsWire